Monitoring Neurochemistry in Traumatic Brain Injury Patients Using Microdialysis Integrated with Biosensors: A Review.
View / Open Files
Publication Date
2022-04-26Journal Title
Metabolites
ISSN
2218-1989
Publisher
MDPI AG
Type
Article
This Version
AM
Metadata
Show full item recordCitation
Zimphango, C., Alimagham, F., Carpenter, K., Hutchinson, P., & Hutter, T. (2022). Monitoring Neurochemistry in Traumatic Brain Injury Patients Using Microdialysis Integrated with Biosensors: A Review.. Metabolites https://doi.org/10.3390/metabo12050393
Abstract
In a traumatically injured brain, the cerebral microdialysis technique allows continuous sampling of fluid from the brain's extracellular space. The retrieved brain fluid contains useful metabolites that indicate the brain's energy state. Assessment of these metabolites along with other parameters, such as intracranial pressure, brain tissue oxygenation, and cerebral perfusion pressure, may help inform clinical decision making, guide medical treatments, and aid in the prognostication of patient outcomes. Currently, brain metabolites are assayed on bedside analysers and results can only be achieved hourly. This is a major drawback because critical information within each hour is lost. To address this, recent advances have focussed on developing biosensing techniques for integration with microdialysis to achieve continuous online monitoring. In this review, we discuss progress in this field, focusing on various types of sensing devices and their ability to quantify specific cerebral metabolites at clinically relevant concentrations. Important points that require further investigation are highlighted, and comments on future perspectives are provided.
Sponsorship
National Institute for Health Research Invention for Innovation Awards (NIHR i4i Challenge Award and NIHR i4i Product Development Award) and the NIHR Brain Injury MedTech Co-operative. C.Z. is supported by a Research Studentship from the W.D. Armstrong Trust (Uni-versity of Cambridge). F.C.A. is supported by an NIHR i4i Product Development Award. K.L.H.C. is supported by the NIHR Biomedical Research Centre, Cambridge and by an NIHR i4i Product Development Award. P.J.H. is supported by the NIHR Biomedical Research Centre Cambridge, NIHR Senior Investigator Award, and the Royal College of Surgeons of England.
Funder references
Cambridge University Hospitals NHS Foundation Trust (CUH) (unknown)
Cambridge University Hospitals NHS Foundation Trust (CUH) (146281)
Identifiers
External DOI: https://doi.org/10.3390/metabo12050393
This record's URL: https://www.repository.cam.ac.uk/handle/1810/336289
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.